1 publication

• Published Subscription Review Article 30 Jan 2025

  FDA Drug Approvals 2024: A Comprehensive Review

  By Komal G. Sangu, Shweta R. Gupta, Pranita D. Shigwan, Kajal S. Prajapati, Anchal P. Verma

  Abstract: The year 2024 has been pivotal for the pharmaceutical industry, with the U.S. Food and Drug Administration (FDA) granting approval to a diverse array of new drugs. These approvals highlight significant strides in therapeutic innovation, targeting a spectrum of diseases from rare genetic disorders to prevalent chronic conditions. This article provides a detailed examination of the FDA-approved drugs of 2024, focusing on their therapeutic indications, mechanisms of action, and the …

  Published in Research & Reviews: A Journal of Drug Formulation, Development and Production · Vol. 12, Issue 1, 2025 · pp. 28–46 Read article →